<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prescription Drugs &#187; Clindamycin</title>
	<atom:link href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/feed" rel="self" type="application/rss+xml" />
	<link>http://www.prescriptiondrugs2go.com</link>
	<description>Popoular Prescription Drugs Latest News</description>
	<lastBuildDate>Fri, 10 Sep 2010 08:00:04 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>CLINDAMYCIN HYDROCHLORIDEcapsule [Watson Laboratories, Inc.]</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-hydrochloridecapsule-watson-laboratories-inc.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-hydrochloridecapsule-watson-laboratories-inc.html#comments</comments>
		<pubDate>Fri, 10 Sep 2010 08:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-hydrochloridecapsule-watson-laboratories-inc.html</guid>
		<description><![CDATA[Updated Date: Sep 7, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
CLINDAMYCIN HYDROCHLORIDEcapsule [Watson Laboratories, Inc.] is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-hydrochloridecapsule-watson-laboratories-inc.html">CLINDAMYCIN HYDROCHLORIDEcapsule [Watson Laboratories, Inc.]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Sep 7, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-hydrochloridecapsule-watson-laboratories-inc.html">CLINDAMYCIN HYDROCHLORIDEcapsule [Watson Laboratories, Inc.]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-hydrochloridecapsule-watson-laboratories-inc.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clindamycin: Acute oedema of the larynx: 2 case reports</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-acute-oedema-of-the-larynx-2-case-reports.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-acute-oedema-of-the-larynx-2-case-reports.html#comments</comments>
		<pubDate>Fri, 10 Sep 2010 08:00:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-acute-oedema-of-the-larynx-2-case-reports.html</guid>
		<description><![CDATA[(Source: Reactions)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

Clindamycin: Acute oedema of the larynx: 2 case reports is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-acute-oedema-of-the-larynx-2-case-reports.html">Clindamycin: Acute oedema of the larynx: 2 case reports</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>(Source: Reactions)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-acute-oedema-of-the-larynx-2-case-reports.html">Clindamycin: Acute oedema of the larynx: 2 case reports</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clindamycin-acute-oedema-of-the-larynx-2-case-reports.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinical Spectrum of Desquamative Inflammatory Vaginitis</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clinical-spectrum-of-desquamative-inflammatory-vaginitis.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clinical-spectrum-of-desquamative-inflammatory-vaginitis.html#comments</comments>
		<pubDate>Mon, 06 Sep 2010 02:27:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clinical-spectrum-of-desquamative-inflammatory-vaginitis.html</guid>
		<description><![CDATA[Abstract&#160;&#160;Desquamative inflammatory vaginitis (DIV) is a rare chronic clinical syndrome of unknown etiology characterized by profuse
 purulent vaginal discharge, diffuse exudative vaginitis, epithelial cell exfoliation, and pain. A diagnosis of DIV is often
 missed by even experienced practitioners owing to its rarity and its clinical and laboratory presentation similar to other
 inflammatory vulvovaginal disorders. Although DIV is difficult to treat and often requires long-term therapy for maintenance,
 successful therapy has been reported with topical steroids and Clindamycin.
	Content Type Journal ArticleDOI 10.1007/s11908-010-0135-yAuthors
		Colleen Kennedy Stockdale, Department of Obstetrics and Gynecology, University of ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clinical-spectrum-of-desquamative-inflammatory-vaginitis.html">Clinical Spectrum of Desquamative Inflammatory Vaginitis</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Abstract&nbsp;&nbsp;Desquamative inflammatory vaginitis (DIV) is a rare chronic clinical syndrome of unknown etiology characterized by profuse<br />
 purulent vaginal discharge, diffuse exudative vaginitis, epithelial cell exfoliation, and pain. A diagnosis of DIV is often<br />
 missed by even experienced practitioners owing to its rarity and its clinical and laboratory presentation similar to other<br />
 inflammatory vulvovaginal disorders. Although DIV is difficult to treat and often requires long-term therapy for maintenance,<br />
 successful therapy has been reported with topical steroids and <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a>.</p>
<p>	Content Type Journal ArticleDOI 10.1007/s11908-010-0135-yAuthors<br />
		Colleen Kennedy Stockdale, Department of Obstetrics and Gynecology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA<br />
&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clinical-spectrum-of-desquamative-inflammatory-vaginitis.html">Clinical Spectrum of Desquamative Inflammatory Vaginitis</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/clinical-spectrum-of-desquamative-inflammatory-vaginitis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>This Issue At A Glance</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/this-issue-at-a-glance.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/this-issue-at-a-glance.html#comments</comments>
		<pubDate>Fri, 03 Sep 2010 13:00:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/this-issue-at-a-glance.html</guid>
		<description><![CDATA[In a retrospective medical record review of 12 patients with posterior pole (zone 1) toxoplasmic retinochoroiditis (TRC), Lasave et al (p. 1831) have found that intravitreal Clindamycin and dexamethasone is associated with resolution of the condition. The patients were placed on the medication due to an intolerance to oral medication, contraindication to oral medication due to pregnancy, or a lack of response despite oral antimicrobial treatment. The patients included in the study were treated weekly with intravitreal injections of Clindamycin (1.5 mg/0.1 ml) and dexamethasone (400 μg/0.1 ml), with an ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/this-issue-at-a-glance.html">This Issue At A Glance</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>In a retrospective medical record review of 12 patients with posterior pole (zone 1) toxoplasmic retinochoroiditis (TRC), Lasave et al (p. 1831) have found that intravitreal <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a> and dexamethasone is associated with resolution of the condition. The patients were placed on the medication due to an intolerance to oral medication, contraindication to oral medication due to pregnancy, or a lack of response despite oral antimicrobial treatment. The patients included in the study were treated weekly with intravitreal injections of <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a> (1.5 mg/0.1 ml) and dexamethasone (400 μg/0.1 ml), with an average of 3.6 injections. (The pregnant patients were treated every 4 weeks). The treatment resolved inflammation and in most cases was associated with improvement of visual acuity and cent&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/this-issue-at-a-glance.html">This Issue At A Glance</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/this-issue-at-a-glance.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A fatal Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus and concomitant Fahr’s syndrome</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/a-fatal-mycobacterium-chelonae-infection-in-an-immunosuppressed-patient-with-systemic-lupus-erythematosus-and-concomitant-fahr%e2%80%99s-syndrome.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/a-fatal-mycobacterium-chelonae-infection-in-an-immunosuppressed-patient-with-systemic-lupus-erythematosus-and-concomitant-fahr%e2%80%99s-syndrome.html#comments</comments>
		<pubDate>Wed, 01 Sep 2010 02:28:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/a-fatal-mycobacterium-chelonae-infection-in-an-immunosuppressed-patient-with-systemic-lupus-erythematosus-and-concomitant-fahr%e2%80%99s-syndrome.html</guid>
		<description><![CDATA[We present a case of systemic Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus (SLE), idiopathic hypoparathyroidism, and hypothyroidism.
 The patient was treated for 3 months for skin infection with clarithromycin monotherapy. Since her condition deteriorated,
 the antibiotic therapy was switched to intravenously administered Clindamycin, cloxacillin, and meropenem. Due to further
 deterioration and isolation of M. chelonae from the blood culture, antimicrobial therapy was changed to azithromycin and amikacin. Drug-test sensitivity was performed,
 and the isolate was susceptible to clarithromycin only. The patient’s deteriorating status prevented orally ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/a-fatal-mycobacterium-chelonae-infection-in-an-immunosuppressed-patient-with-systemic-lupus-erythematosus-and-concomitant-fahr%e2%80%99s-syndrome.html">A fatal Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus and concomitant Fahr’s syndrome</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>We present a case of systemic Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus (SLE), idiopathic hypoparathyroidism, and hypothyroidism.<br />
 The patient was treated for 3 months for skin infection with clarithromycin monotherapy. Since her condition deteriorated,<br />
 the antibiotic therapy was switched to intravenously administered <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a>, cloxacillin, and meropenem. Due to further<br />
 deterioration and isolation of M. chelonae from the blood culture, antimicrobial therapy was changed to azithromycin and amikacin. Drug-test sensitivity was performed,<br />
 and the isolate was susceptible to clarithromycin only. The patient’s deteriorating status prevented orally administered medication<br />
 with clarithromycin (parenteral formulation is not registered &#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/a-fatal-mycobacterium-chelonae-infection-in-an-immunosuppressed-patient-with-systemic-lupus-erythematosus-and-concomitant-fahr%e2%80%99s-syndrome.html">A fatal Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus and concomitant Fahr’s syndrome</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/a-fatal-mycobacterium-chelonae-infection-in-an-immunosuppressed-patient-with-systemic-lupus-erythematosus-and-concomitant-fahr%e2%80%99s-syndrome.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Intravitreal Injections Might Be Best for Ocular Toxoplasmosis: Study</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/intravitreal-injections-might-be-best-for-ocular-toxoplasmosis-study.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/intravitreal-injections-might-be-best-for-ocular-toxoplasmosis-study.html#comments</comments>
		<pubDate>Fri, 27 Aug 2010 13:20:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/intravitreal-injections-might-be-best-for-ocular-toxoplasmosis-study.html</guid>
		<description><![CDATA[Intravitreal injection of Clindamycin and dexamethasone for active ocular toxoplasmosis may be safer and more convenient than standard treatment, according to researchers in Iran.  Reuters Health Information (Source: Medscape Pharmacist Headlines)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 free advertising.

Intravitreal Injections Might Be Best for Ocular Toxoplasmosis: Study is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/intravitreal-injections-might-be-best-for-ocular-toxoplasmosis-study.html">Intravitreal Injections Might Be Best for Ocular Toxoplasmosis: Study</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Intravitreal injection of <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a> and dexamethasone for active ocular toxoplasmosis may be safer and more convenient than standard treatment, according to researchers in Iran.  Reuters Health Information (Source: Medscape Pharmacist Headlines)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/intravitreal-injections-might-be-best-for-ocular-toxoplasmosis-study.html">Intravitreal Injections Might Be Best for Ocular Toxoplasmosis: Study</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/intravitreal-injections-might-be-best-for-ocular-toxoplasmosis-study.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated MRSA.</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/subinhibitory-concentrations-of-protein-synthesis-inhibiting-antibiotics-promote-increased-expression-of-the-agr-virulence-regulator-and-production-of-phenol-soluble-modulin-cytolysins-in-community-as.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/subinhibitory-concentrations-of-protein-synthesis-inhibiting-antibiotics-promote-increased-expression-of-the-agr-virulence-regulator-and-production-of-phenol-soluble-modulin-cytolysins-in-community-as.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 08:00:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/subinhibitory-concentrations-of-protein-synthesis-inhibiting-antibiotics-promote-increased-expression-of-the-agr-virulence-regulator-and-production-of-phenol-soluble-modulin-cytoly</guid>
		<description><![CDATA[Authors: Joo HS, Chan JL, Cheung GY, Otto M
    Tetracycline, Clindamycin, and other protein synthesis inhibitors at subinhibitory concentrations significantly increased expression of the pivotal virulence regulator agr and production of the agr-regulated cytolytic phenol-soluble modulins in the community-associated MRSA strain USA300. Our results suggest that such protein synthesis inhibitors may exacerbate progression of CA-MRSA disease when applied at concentrations that are too low or when treating infections caused by strains resistant to those antibiotics.
    PMID: 20713669 [PubMed - as supplied by publisher] (Source: ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/subinhibitory-concentrations-of-protein-synthesis-inhibiting-antibiotics-promote-increased-expression-of-the-agr-virulence-regulator-and-production-of-phenol-soluble-modulin-cytolysins-in-community-as.html">Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated MRSA.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Authors: Joo HS, Chan JL, Cheung GY, Otto M<br />
    Tetracycline, <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a>, and other protein synthesis inhibitors at subinhibitory concentrations significantly increased expression of the pivotal virulence regulator agr and production of the agr-regulated cytolytic phenol-soluble modulins in the community-associated MRSA strain USA300. Our results suggest that such protein synthesis inhibitors may exacerbate progression of CA-MRSA disease when applied at concentrations that are too low or when treating infections caused by strains resistant to those antibiotics.<br />
    PMID: 20713669 [PubMed - as supplied by publisher] (Source: Antimicrobial Agents and Chemotherapy)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/subinhibitory-concentrations-of-protein-synthesis-inhibiting-antibiotics-promote-increased-expression-of-the-agr-virulence-regulator-and-production-of-phenol-soluble-modulin-cytolysins-in-community-as.html">Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated MRSA.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/subinhibitory-concentrations-of-protein-synthesis-inhibiting-antibiotics-promote-increased-expression-of-the-agr-virulence-regulator-and-production-of-phenol-soluble-modulin-cytolysins-in-community-as.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EVOCLIN (Clindamycin Phosphate) Aerosol, Foam [Stiefel Laboratories Inc]</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/evoclin-clindamycin-phosphate-aerosol-foam-stiefel-laboratories-inc-3.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/evoclin-clindamycin-phosphate-aerosol-foam-stiefel-laboratories-inc-3.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 08:00:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/evoclin-clindamycin-phosphate-aerosol-foam-stiefel-laboratories-inc-3.html</guid>
		<description><![CDATA[Updated Date: Aug 24, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
EVOCLIN (Clindamycin Phosphate) Aerosol, Foam [Stiefel Laboratories Inc] is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/evoclin-clindamycin-phosphate-aerosol-foam-stiefel-laboratories-inc-3.html">EVOCLIN (Clindamycin Phosphate) Aerosol, Foam [Stiefel Laboratories Inc]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Aug 24, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/evoclin-clindamycin-phosphate-aerosol-foam-stiefel-laboratories-inc-3.html">EVOCLIN (Clindamycin Phosphate) Aerosol, Foam [Stiefel Laboratories Inc]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/evoclin-clindamycin-phosphate-aerosol-foam-stiefel-laboratories-inc-3.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-3.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-3.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 08:00:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-3.html</guid>
		<description><![CDATA[Conclusions: Fifty percent of Staphylococcal spp. were ER among which 23.48&#x25; were iMLS B phenotypes. Eighty-seven per cent of iMLS B phenotypes were observed to be methicillin-resistant. The high frequency of methicillin resistance isolates (87.12&#x25;) with in vitro inducible Clindamycin resistance at our institute raises concern of Clindamycin treatment failures with methicillin-resistant infections. So we recommend that microbiology laboratories should include the D-test for inducible resistance to Clindamycin in the routine antibiotic susceptibility testing. (Source: Journal of Postgraduate Medicine)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-3.html">Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Conclusions: Fifty percent of Staphylococcal spp. were ER among which 23.48&#x25; were iMLS B phenotypes. Eighty-seven per cent of iMLS B phenotypes were observed to be methicillin-resistant. The high frequency of methicillin resistance isolates (87.12&#x25;) with in vitro inducible <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a> resistance at our institute raises concern of <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a> treatment failures with methicillin-resistant infections. So we recommend that microbiology laboratories should include the D-test for inducible resistance to <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a> in the routine antibiotic susceptibility testing. (Source: Journal of Postgraduate Medicine)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-3.html">Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-3.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/antimicrobial-resistance-in-colonizing-group-b-streptococci-before-the-implementation-of-a-swedish-intrapartum-antibiotic-prophylaxis-program.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/antimicrobial-resistance-in-colonizing-group-b-streptococci-before-the-implementation-of-a-swedish-intrapartum-antibiotic-prophylaxis-program.html#comments</comments>
		<pubDate>Mon, 16 Aug 2010 13:20:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clindamycin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/antimicrobial-resistance-in-colonizing-group-b-streptococci-before-the-implementation-of-a-swedish-intrapartum-antibiotic-prophylaxis-program.html</guid>
		<description><![CDATA[Abstract&#160;&#160;The prevalence of antibiotic resistance and their genetic determinants in colonizing group B streptococci (GBS) sampled in
 a Swedish nationwide survey was examined. In five GBS isolates (1.3%), kanamycin/amikacin resistance and the presence of the
 aphA-3 gene was identified. Three of these isolates carried the aad-6 gene and were streptomycin-resistant. Screening with kanamycin and streptomycin 1,000-μg disks enabled a rapid and easy detection
 of these isolates. In all, 312/396 (79%) GBS were tetracycline-resistant and 95% of the examined isolates harbored the tetM gene. Among the 22 (5.5%) GBS resistant to ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/antimicrobial-resistance-in-colonizing-group-b-streptococci-before-the-implementation-of-a-swedish-intrapartum-antibiotic-prophylaxis-program.html">Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Abstract&nbsp;&nbsp;The prevalence of antibiotic resistance and their genetic determinants in colonizing group B streptococci (GBS) sampled in<br />
 a Swedish nationwide survey was examined. In five GBS isolates (1.3%), kanamycin/amikacin resistance and the presence of the<br />
 aphA-3 gene was identified. Three of these isolates carried the aad-6 gene and were streptomycin-resistant. Screening with kanamycin and streptomycin 1,000-μg disks enabled a rapid and easy detection<br />
 of these isolates. In all, 312/396 (79%) GBS were tetracycline-resistant and 95% of the examined isolates harbored the tetM gene. Among the 22 (5.5%) GBS resistant to erythromycin and/or <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin">Clindamycin</a>, the ermB gene was detected in nine isolates (41%) and erm(A/TR) in ten isolates (45%). A high level of erythromycin and clindamy&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/antimicrobial-resistance-in-colonizing-group-b-streptococci-before-the-implementation-of-a-swedish-intrapartum-antibiotic-prophylaxis-program.html">Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/clindamycin/antimicrobial-resistance-in-colonizing-group-b-streptococci-before-the-implementation-of-a-swedish-intrapartum-antibiotic-prophylaxis-program.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
